Beacon Investment Advisory Services, Inc. Gilead Sciences, Inc. Transaction History
Beacon Investment Advisory Services, Inc.
- $2.29 Billion
- Q4 2024
A detailed history of Beacon Investment Advisory Services, Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Beacon Investment Advisory Services, Inc. holds 80,232 shares of GILD stock, worth $7.46 Million. This represents 0.32% of its overall portfolio holdings.
Number of Shares
80,232
Previous 76,595
4.75%
Holding current value
$7.46 Million
Previous $6.42 Million
15.44%
% of portfolio
0.32%
Previous 0.27%
Shares
30 transactions
Others Institutions Holding GILD
# of Institutions
1,939Shares Held
994MCall Options Held
10.5MPut Options Held
9.75M-
Black Rock Inc. New York, NY121MShares$11.2 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA115MShares$10.7 Billion0.18% of portfolio
-
Capital World Investors Los Angeles, CA76.5MShares$7.11 Billion1.03% of portfolio
-
Capital Research Global Investors Los Angeles, CA61.8MShares$5.74 Billion1.12% of portfolio
-
State Street Corp Boston, MA60.2MShares$5.59 Billion0.21% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $116B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...